{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:31:07Z","timestamp":1789486267809,"version":"build-2803163510"},"reference-count":105,"publisher":"Walter de Gruyter GmbH","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adverse event in the perinatal period constitutes today the wider bulk of investigation. Perinatal asphyxia (PA) and prematurity are the common causes of injury of high risk pregnancies (HR) and can lead to perinatal death or cognitive and neuro-motor impairment in later life. Despite the use of clinical, laboratory, ultrasound and radiological monitoring procedures, for the estimation of the severity of pre-perinatal brain injury and prognosis, there is still a demand for an early and objective diagnostic and prognostic parameter. Former research suggests that several neurobiomarkers could serve as potential both diagnostic and prognostic tools in HR and newborns. Among them, S100B is a well-known biomarker that could be assessed in different biological fluids such as maternal blood. The inclusion in clinical daily practice of a biomarker, measurable in the maternal blood, able to detect at earliest stage fetal\/neonatal neurological damage is of utmost importance. Therefore, in the present review we offer an update of the potential usefulness of the measurement in the maternal blood of a well-established marker of perinatal brain development\/damage namely S100B.<\/jats:p>","DOI":"10.1515\/cclm-2025-1673","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:58:34Z","timestamp":1776653914000},"page":"1919-1929","source":"Crossref","is-referenced-by-count":0,"title":["S100B measurement in the maternal blood: a new promising tool for fetal well-being\/distress monitoring?"],"prefix":"10.1515","volume":"64","author":[{"given":"Laura","family":"Abella","sequence":"first","affiliation":[{"name":"Department of Pediatric Anesthesia and Resuscitation Hospital Vall d\u2019Hebron , Barcelona , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Levantini","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, G. d\u2019Annunzio University of Chieti , Chieti , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Strozzi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Neonatology , Ospedale Cardinal Massaia , Asti , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Maconi","sequence":"additional","affiliation":[{"name":"Social Security Administration Development and Promotion of Scientific Research Unit, SS Antonio, Biagio and C. Arrigo Hospital , Alessandria , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Bellinaso","sequence":"additional","affiliation":[{"name":"Department of Maternal, Fetal and Neonatal Medicine , SS Antonio, Biagio and C. Arrigo Hospital , Alessandria , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Di Clemente","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Pathology , SS Annunziata Hospital , Chieti , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"de Laurenzi","sequence":"additional","affiliation":[{"name":"Center for Advances Studies and Technology (CAST) , G. d\u2019Annunzio University , Chieti , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gazzolo","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, G. d\u2019Annunzio University of Chieti , Chieti , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebe","family":"D\u2019Adamo","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, G. d\u2019Annunzio University of Chieti , Chieti , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Gazzolo","sequence":"additional","affiliation":[{"name":"Neonatal Intensive Care Unit, G. d\u2019Annunzio University of Chieti , Chieti , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"2026091512595703013_j_cclm-2025-1673_ref_001","doi-asserted-by":"crossref","unstructured":"Wong, C, Crawford, K, Hong, J, Rosser, S, Flenady, V, Leisher, S, et al.. Maternal risk stratification and planned birth improve pregnancy outcomes at term: a population-based cohort study. Am J Obstet Gynecol 2025;15. S0002-9378(25)00733-1. https:\/\/doi.org\/10.1016\/j.ajog.2025.10.005.","DOI":"10.1016\/j.ajog.2025.10.005"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_002","doi-asserted-by":"crossref","unstructured":"Van den Heuvel, JFM, Groenhof, TK, Veerbeek, JH, Van Solinge, WW, Lely, AT, Franx, A, et al.. eHealth as the next-generation perinatal care: an overview of the literature. J Med Internet Res 2018;20:e202\u201310. https:\/\/doi.org\/10.2196\/jmir.9262.","DOI":"10.2196\/jmir.9262"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_003","doi-asserted-by":"crossref","unstructured":"Herrera, CA, Silver, RM. Perinatal asphyxia from the obstetric standpoint. Clin Perinatol 2016;43:423\u201338. https:\/\/doi.org\/10.1016\/j.clp.2016.04.003.","DOI":"10.1016\/j.clp.2016.04.003"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_004","doi-asserted-by":"crossref","unstructured":"Michetti, F, Corvino, V, Geloso, MC, Lattanzi, W, Bernardini, C, Serpero, L, et al.. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J Neurochem 2012;120:644\u201359. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07612.x.","DOI":"10.1111\/j.1471-4159.2011.07612.x"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_005","doi-asserted-by":"crossref","unstructured":"Bersani, I, Pluchinotta, F, Dotta, A, Savarese, I, Campi, F, Auriti, C, et al.. Early predictors of perinatal brain damage: the role of neurobiomarkers. Clin Chem Lab Med 2020;58:471\u201386. https:\/\/doi.org\/10.1515\/cclm-2019-0725.","DOI":"10.1515\/cclm-2019-0725"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_006","doi-asserted-by":"crossref","unstructured":"Garnier, Y, Frigiola, A, Li Volti, G, Florio, P, Frulio, R, Berger, R, et al.. Increased maternal\/fetal blood S100B levels following systemic endotoxin administration and periventricular white matter injury in preterm fetal sheep. Reprod Sci 2009;16:758\u201366. https:\/\/doi.org\/10.1177\/1933719109335801.","DOI":"10.1177\/1933719109335801"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_007","doi-asserted-by":"crossref","unstructured":"Gazzolo, D, Marinoni, E, Di Iorio, R, Lituania, M, Marras, M, Bruschettini, M, et al.. High maternal blood S100B concentrations in pregnancies complicated by intrauterine growth restriction and intraventricular hemorrhage. Clin Chem 2006;52:819\u201326. https:\/\/doi.org\/10.1373\/clinchem.2005.060665.","DOI":"10.1373\/clinchem.2005.060665"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_008","doi-asserted-by":"crossref","unstructured":"Abella, L, D\u2019Adamo, E, Strozzi, M, Botondi, V, Abella, E, Cassinari, M, et al.. Early changes in S100B maternal blood levels can predict fetal intrauterine growth restriction. Clin Chem Lab Med 2023;61:2205\u201311. https:\/\/doi.org\/10.1515\/cclm-2023-0294.","DOI":"10.1515\/cclm-2023-0294"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_009","doi-asserted-by":"crossref","unstructured":"Misan, N, Michalak, S, Rzymski, P, Poniedzia\u0142ek, B, Kapska, K, Osztynowicz, K, et al.. Molecular indicators of blood-brain barrier breakdown and neuronal injury in pregnancy complicated by fetal growth restriction. Int J Mol Sci 2022;23:13798. https:\/\/doi.org\/10.3390\/ijms232213798.","DOI":"10.3390\/ijms232213798"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_010","doi-asserted-by":"crossref","unstructured":"Sannia, A, Zimmermann, LJ, Gavilanes, AW, Vles, HJ, Serpero, LD, Frulio, R, et al.. S100B protein maternal and fetal bloodstreams gradient in healthy and small for gestational age pregnancies. Clin Chim Acta 2011;412:1337\u201340. https:\/\/doi.org\/10.1016\/j.cca.2011.03.034.","DOI":"10.1016\/j.cca.2011.03.034"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_011","doi-asserted-by":"crossref","unstructured":"Serpero, LD, Bianchi, V, Pluchinotta, F, Conforti, E, Baryshnikova, E, Guaschino, R, et al.. S100B maternal blood levels are gestational age- and gender-dependent in healthy pregnancies. Clin Chem Lab Med 2017;55:1770\u20136. https:\/\/doi.org\/10.1515\/cclm-2016-1127.","DOI":"10.1515\/cclm-2016-1127"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_012","doi-asserted-by":"crossref","unstructured":"Moore, BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965;19:739\u201344. https:\/\/doi.org\/10.1016\/0006-291x(65)90320-7.","DOI":"10.1016\/0006-291X(65)90320-7"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_013","unstructured":"Haimoto, H, Hosoda, S, Kato, K. Differential distribution of immunoreactive S100-\u03b1 and S100-\u03b2 proteins in normal non-nervous human tissues. Lab Invest 1987;57:489\u201398."},{"key":"2026091512595703013_j_cclm-2025-1673_ref_014","doi-asserted-by":"crossref","unstructured":"Stefansson, K, Wollmann, RL, Moore, BW, Arnason, BG. S-100 protein in human chondrocytes. Nature 1982;295:63\u20134. https:\/\/doi.org\/10.1038\/295063a0.","DOI":"10.1038\/295063a0"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_015","doi-asserted-by":"crossref","unstructured":"Lauriola, L, Maggiano, N, Sentinelli, S, Michetti, F, Cocchia, D. Satellite cells in the normal human adrenal gland and in pheochromocytomas. Virchows Arch B\u00a0Cell Pathol Incl Mol Pathol 1985;49:13\u201321. https:\/\/doi.org\/10.1007\/bf02912081.","DOI":"10.1007\/BF02912081"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_016","doi-asserted-by":"crossref","unstructured":"Michetti, F, Dell\u2019Anna, E, Tiberio, G, Cocchia, D. Immunochemical and immunocytochemical study of S-100 protein in rat adipocytes. Brain Res 1983;262:352\u20136. https:\/\/doi.org\/10.1016\/0006-8993(83)91032-6.","DOI":"10.1016\/0006-8993(83)91032-6"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_017","doi-asserted-by":"crossref","unstructured":"Tubaro, C, Arcuri, C, Giambanco, I, Donato, R. S100B protein in myoblasts modulates myogenic differentiation via NF-\u03baB-dependent inhibition of MyoD expression. J Cell Physiol 2010;223:270\u201382. https:\/\/doi.org\/10.1002\/jcp.22035.","DOI":"10.1002\/jcp.22035"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_018","doi-asserted-by":"crossref","unstructured":"Heierhorst, J, Kobe, B, Feil, SC, Parker, MW, Benians, GM, Weiss, KR, et al.. Calcium\/S100 regulation of giant protein kinases. Nature 1996;380:636\u20139. https:\/\/doi.org\/10.1038\/380636a0.","DOI":"10.1038\/380636a0"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_019","doi-asserted-by":"crossref","unstructured":"Michetti, F, D\u2019Ambrosi, N, Toesca, A, Puglisi, MA, Serrano, A, Marchese, E, et al.. The S100B story: from biomarker to active factor in the neural injury. J Neurochem 2019;148:168\u201387. https:\/\/doi.org\/10.1111\/jnc.14574.","DOI":"10.1111\/jnc.14574"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_020","doi-asserted-by":"crossref","unstructured":"Pham, N, Fazio, V, Cucullo, L, Teng, Q, Biberthaler, P, Bazarian, JJ, et al.. Extracranial sources of S100B do not affect serum levels. PLoS One 2010;5:e12691, https:\/\/doi.org\/10.1371\/journal.pone.0012691.","DOI":"10.1371\/journal.pone.0012691"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_021","doi-asserted-by":"crossref","unstructured":"Misan, N, Michalak, S, Kapska, K, Osztynowicz, K, Ropacka-Lesiak, M, Kawka-Paciorkowska, K. Does the blood-brain barrier integrity change in regard to the onset of fetal growth restriction? Int J Mol Sci 2023;24:1965. https:\/\/doi.org\/10.3390\/ijms24031965.","DOI":"10.3390\/ijms24031965"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_022","doi-asserted-by":"crossref","unstructured":"Baudier, J, Cole, RD. Interactions between the microtubule associated tau proteins and S100b regulate tau phosphorylation by the Ca2+\/calmodulin-dependent protein kinase II. J Biol Chem 1988;263:5876\u201383. https:\/\/doi.org\/10.1016\/s0021-9258(18)60647-7.","DOI":"10.1016\/S0021-9258(18)60647-7"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_023","doi-asserted-by":"crossref","unstructured":"Millward, TA, Heizmann, CW, Schaefer, BW, Hemmings, BA. Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J 1998;17:5913\u201322. https:\/\/doi.org\/10.1093\/emboj\/17.20.5913.","DOI":"10.1093\/emboj\/17.20.5913"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_024","doi-asserted-by":"crossref","unstructured":"Arcuri, C, Bianchi, R, Brozzi, F, Donato, R. S100B increases proliferation in PC12 neuronal cells and reduces their responsive-ness to NGF via Akt activation. J Biol Chem 2005;280:4402\u201314. https:\/\/doi.org\/10.1074\/jbc.m406440200.","DOI":"10.1074\/jbc.M406440200"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_025","doi-asserted-by":"crossref","unstructured":"Raponi, E, Agenes, F, Delphin, C, Assard, N, Baudier, J, Legraverend, C, et al.. S100B expression defines a state in which GFAP-expressing cells lose their neural stem potential and acquire a more mature developmental stage. Glia 2007;55:165\u201377. https:\/\/doi.org\/10.1002\/glia.20445.","DOI":"10.1002\/glia.20445"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_026","doi-asserted-by":"crossref","unstructured":"Xiong, Z, O\u2019Hanlon, D, Becker, LE, Roder, J, MacDonald, JF, Marks, A. Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice. Exp Cell Res 2000;257:281\u20139. https:\/\/doi.org\/10.1006\/excr.2000.4902.","DOI":"10.1006\/excr.2000.4902"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_027","doi-asserted-by":"crossref","unstructured":"Gentil, BJ, Delphin, C, Mbele, GO, Deloulme, JC, Ferro, M, Garin, J, et al.. The giant protein AHNAK is a specific target for the calcium- and zinc-binding S100B protein: potential implications for calcium homeostasis regulation by S100B. J Biol Chem 2001;276:23253\u201361. https:\/\/doi.org\/10.1074\/jbc.m010655200.","DOI":"10.1074\/jbc.M010655200"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_028","doi-asserted-by":"crossref","unstructured":"Pozdnyakoz, N, Gorazniak, R, Margulis, A, Duda, T, Sharma, RK, Yoshida, A, et al.. Structural and functional characterization of retinal calcium-dependent quanylate cyclise activator protein (CD-GCAP): identity with S100beta protein. Biochemistry 1997;36:159\u201366.","DOI":"10.1021\/bi971792l"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_029","doi-asserted-by":"crossref","unstructured":"Brozzi, F, Arcuri, C, Giambanco, I, Donato, R. S100B protein regulates astrocyte shape and migration via interaction with Src kinase: implications for astrocyte development, activation, and tumor growth. J Biol Chem 2009;284:8797\u2013811. https:\/\/doi.org\/10.1074\/jbc.m805897200.","DOI":"10.1074\/jbc.M805897200"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_030","doi-asserted-by":"crossref","unstructured":"Michetti, F, Massaro, A, Murazio, M. The nervous system-specific S-100 antigen in cerebrospinal fluid of multiple sclerosis patients. Neurosci Lett 1979;11:171\u20135. https:\/\/doi.org\/10.1016\/0304-3940(79)90122-8.","DOI":"10.1016\/0304-3940(79)90122-8"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_031","doi-asserted-by":"crossref","unstructured":"Gazzolo, D, Marinoni, E, Di Iorio, R, Lituania, M, Bruschettini, P, Michetti, F. Circulating S-100B protein is increased in intrauterine growth\u2010retarded fetuses. Pediatr Res 2002;51:215\u20139. https:\/\/doi.org\/10.1203\/00006450-200202000-00015.","DOI":"10.1203\/00006450-200202000-00015"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_032","doi-asserted-by":"crossref","unstructured":"Gazzolo, D, Vinesi, P, Marinoni, E, Di Iorio, R, Marras, M, Lituania, M, et al.. S100B protein concentrations in cord blood: correlations with gestational age in term and preterm deliveries. Clin Chem 2000;46:998\u20131000. https:\/\/doi.org\/10.1093\/clinchem\/46.7.998.","DOI":"10.1093\/clinchem\/46.7.998"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_033","doi-asserted-by":"crossref","unstructured":"Gazzolo, D, Bruschettini, M, Corvino, V, Sarli, R, Lituania, M, Bruschettini, PL, et al.. S100B protein concentrations in amniotic fluid are correlated with gestational age and with cerebral ultrasound scanning parameters results in healthy fetuses. Clin Chem 2001;47:954\u20136. https:\/\/doi.org\/10.1093\/clinchem\/47.5.954.","DOI":"10.1093\/clinchem\/47.5.954"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_034","doi-asserted-by":"crossref","unstructured":"Gazzolo, D, Bruschettini, M, Lituania, M, Serra, G, Bonacci, W, Michetti, F. Increased urinary S100B protein as an early indicator of intraventricular hemorrhage in preterm infants: correlation with the grade of hemorrhage. Clin Chem 2001;47:1836\u20138. https:\/\/doi.org\/10.1093\/clinchem\/47.10.1836.","DOI":"10.1093\/clinchem\/47.10.1836"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_035","doi-asserted-by":"crossref","unstructured":"Gazzolo, D, Lituania, M, Bruschettini, M, Ciotti, S, Sacchi, R, Serra, G, et al.. S100B protein levels in saliva: correlation with gestational age in normal term and preterm newborns. Clin Biochem 2005;38:229\u201333. https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.12.006.","DOI":"10.1016\/j.clinbiochem.2004.12.006"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_036","doi-asserted-by":"crossref","unstructured":"Shashoua, VE, Hesse, GW, Moore, BW. Proteins of the brain extracellular fluid: evidence for release of S-100 protein. J Neurochem 1984;42:1536\u201341. https:\/\/doi.org\/10.1111\/j.1471-4159.1984.tb12739.x.","DOI":"10.1111\/j.1471-4159.1984.tb12739.x"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_037","doi-asserted-by":"crossref","unstructured":"Suzuki, F, Kato, K, Nakajima, T. Hormonal regulation of adipose S-100 protein release. J Neurochem 1984;43:1336\u201341. https:\/\/doi.org\/10.1111\/j.1471-4159.1984.tb05391.x.","DOI":"10.1111\/j.1471-4159.1984.tb05391.x"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_038","doi-asserted-by":"crossref","unstructured":"Van Eldik, LJ, Griffin, WS. S100 beta expression in Alzheimer\u2019s disease: relation to neuropathology in brain regions. Biochim Biophys Acta 1994;1223:398\u2013403. https:\/\/doi.org\/10.1016\/0167-4889(94)90101-5.","DOI":"10.1016\/0167-4889(94)90101-5"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_039","doi-asserted-by":"crossref","unstructured":"Zimmer, DB, Van Eldik, LJ. Identification of a molecular target for the calcium-modulated protein S100: fructose-1,6-bisphosphate aldolase. J Biol Chem 1986;261:11424\u20138. https:\/\/doi.org\/10.1016\/s0021-9258(18)67402-2.","DOI":"10.1016\/S0021-9258(18)67402-2"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_040","doi-asserted-by":"crossref","unstructured":"Ellis, EF, Willoughby, KA, Sparks, SA, Chen, T. S100B protein is released from rat neonatal neurons, astrocytes and microglia by in\u00a0vitro trauma and anti-S100 increases trauma-induced delayed neuronal injury and negates the protective effect of exogenous S100B on neurons. J Neurochem 2007;101:1463\u201370. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04515.x.","DOI":"10.1111\/j.1471-4159.2007.04515.x"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_041","doi-asserted-by":"crossref","unstructured":"Gerlach, R, Demnel, G, Konig, HG, Gross, U, Prehn, JH, Raabe, A, et al.. Active secretion of S100B from astrocytes during metabolic stress. Neuroscience 2006;141:1697\u2013701. https:\/\/doi.org\/10.1016\/j.neuroscience.2006.05.008.","DOI":"10.1016\/j.neuroscience.2006.05.008"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_042","doi-asserted-by":"crossref","unstructured":"Kligman, D, Marshak, DR. Purification and characterization of a neurite extension factor from bovine brain. Proc Natl Acad Sci USA 1985;82:7136\u20139. https:\/\/doi.org\/10.1073\/pnas.82.20.7136.","DOI":"10.1073\/pnas.82.20.7136"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_043","doi-asserted-by":"crossref","unstructured":"Marshak, DR, Pesce, SA, Stanley, LC, Griffin, WS. Increased S100 beta neurotrophic activity in Alzheimer\u2019s disease temporal lobe. Neurobiol Aging 1992;13:1\u20137. https:\/\/doi.org\/10.1016\/0197-4580(92)90002-f.","DOI":"10.1016\/0197-4580(92)90002-F"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_044","doi-asserted-by":"crossref","unstructured":"Winningham-Major, F, Staecker, J, Barger, SW, Coats, S, Van Eldik, LJ. Neurite extension and neuronal survival activities of recombinant S100 beta proteins that differ in the content and position of cysteine residues. J Cell Biol 1989;109:3063\u201371. https:\/\/doi.org\/10.1083\/jcb.109.6.3063.","DOI":"10.1083\/jcb.109.6.3063"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_045","doi-asserted-by":"crossref","unstructured":"Bhattacharyya, A, Oppenheim, RW, Prevette, D, Moore, BW, Brackenbury, R, Ratner, N. S100 is present in developing chicken neurons and Schwann cells and promotes motor neuron survival in\u00a0vivo. J Neurobiol 1992;23:451\u201366. https:\/\/doi.org\/10.1002\/neu.480230410.","DOI":"10.1002\/neu.480230410"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_046","doi-asserted-by":"crossref","unstructured":"Haglid, KG, Yang, Q, Hamberger, A, Bergman, S, Widerberg, A, Danielsen, N. S-100\u03b2 stimulates neurite outgrowth in the rat sciatic nerve grafted with acellular muscle transplants. Brain Res 1997;753:196\u2013201. https:\/\/doi.org\/10.1016\/s0006-8993(96)01463-1.","DOI":"10.1016\/S0006-8993(96)01463-1"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_047","doi-asserted-by":"crossref","unstructured":"Barger, SW, Van Eldik, LJ, Mattson, MP. S100 beta protects hippocampal neurons from damage induced by glucose deprivation. Brain Res 1995;677:167\u201370. https:\/\/doi.org\/10.1016\/0006-8993(95)00160-r.","DOI":"10.1016\/0006-8993(95)00160-R"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_048","doi-asserted-by":"crossref","unstructured":"Iwasaki, Y, Shiojima, T, Kinoshita, M. S100 beta prevents the death of motor neurons in newborn rats after sciatic nerve section. J Neurol Sci 1997;151:7\u201312. https:\/\/doi.org\/10.1016\/s0022-510x(97)00073-7.","DOI":"10.1016\/S0022-510X(97)00073-7"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_049","doi-asserted-by":"crossref","unstructured":"Ahlemeyer, B, Beier, H, Semkova, I, Schaper, C, Kriegstein, J. S-100\u03b2 protects cultured neurons against glutamate- and staurosporine-induced damage and is involved in the antiapoptotic action of the 5-HT(1A)-receptor agonist Bay x 3702. Brain Res 2000;858:121\u20138. https:\/\/doi.org\/10.1016\/s0006-8993(99)02438-5.","DOI":"10.1016\/S0006-8993(99)02438-5"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_050","doi-asserted-by":"crossref","unstructured":"Businaro, R, Leone, S, Sorci, G, Donato, R, Lauro, GM, Fumagalli, L. S100B protects LAN-5 neuroblastoma cells against A\u03b2 amyloid-induced neurotoxicity via RAGE engagement at low doses but increases A\u03b2 amyloid neurotoxicity at high doses. J Neurosci Res 2006;83:897\u2013906.","DOI":"10.1002\/jnr.20785"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_051","doi-asserted-by":"crossref","unstructured":"Kleindienst, A, Bullock, MR. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J Neurotrauma 2006;23:1185\u2013200. https:\/\/doi.org\/10.1089\/neu.2006.23.1185.","DOI":"10.1089\/neu.2006.23.1185"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_052","doi-asserted-by":"crossref","unstructured":"Hu, J, Castets, F, Guevara, JL, Van Eldik, LJ. S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J Biol Chem 1996;271:2543\u20137. https:\/\/doi.org\/10.1074\/jbc.271.5.2543.","DOI":"10.1074\/jbc.271.5.2543"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_056","doi-asserted-by":"crossref","unstructured":"Bernardini, C, Lattanzi, W, Businaro, R, Leone, S, Corvino, V, Sorci, G, et al.. Transcriptional effects of S100B on neuroblastoma cells: perturbation of cholesterol homeostasis and interference on the cell cycle. Gene Expr 2010;14:345\u201359. https:\/\/doi.org\/10.3727\/105221610x12718619643013.","DOI":"10.3727\/105221610X12718619643013"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_057","doi-asserted-by":"crossref","unstructured":"Bianchi, R, Giambanco, I, Donato, R. S100B\/RAGE-dependent activation of microglia via NF-\u03baB and AP-1. Neurobiol Aging 2010;31:665\u201377. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.05.017.","DOI":"10.1016\/j.neurobiolaging.2008.05.017"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_058","doi-asserted-by":"crossref","unstructured":"Taguchi, K, Fukami, K. RAGE signaling regulates the progression of diabetic complications. Front Pharmacol 2023;14:1128872. https:\/\/doi.org\/10.3389\/fphar.2023.1128872.","DOI":"10.3389\/fphar.2023.1128872"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_053","doi-asserted-by":"crossref","unstructured":"Sorci, G, Riuzzi, F, Agneletti, AL, Marchetti, C, Donato, R. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol Cell Biol 2003;23:4870\u201381. https:\/\/doi.org\/10.1128\/mcb.23.14.4870-4881.2003.","DOI":"10.1128\/MCB.23.14.4870-4881.2003"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_054","doi-asserted-by":"crossref","unstructured":"Huttunen, HJ, Kuja-Panula, J, Sorci, G, Agneletti, AL, Donato, R, Rauvala, H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation. J Biol Chem 2000;275:40096\u2013105. https:\/\/doi.org\/10.1074\/jbc.m006993200.","DOI":"10.1074\/jbc.M006993200"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_055","doi-asserted-by":"crossref","unstructured":"Petrova, TV, Hu, J, Van Eldik, LJ. Modulation of glial activation by astrocyte-derived protein S100B: differential responses of astrocyte and microglial cultures. Brain Res 2000;853:74\u201380. https:\/\/doi.org\/10.1016\/s0006-8993(99)02251-9.","DOI":"10.1016\/S0006-8993(99)02251-9"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_059","doi-asserted-by":"crossref","unstructured":"Allore, R, O\u2019Hanlon, D, Price, R, Neilson, K, Willard, HF, Cox, DR, et al.. Gene encoding the beta-subunit of S100 protein is on chromosome 21: implications for Down\u2019s syndrome. Science 1988;239:1311\u20133. https:\/\/doi.org\/10.1126\/science.2964086.","DOI":"10.1126\/science.2964086"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_060","doi-asserted-by":"crossref","unstructured":"Esposito, G, Imitola, J, Lu, J, De Filippis, D, Scuderi, C, Ganesh, VS, et al.. Genomic and functional profiling of human Down syndrome neural progenitors implicates S100B and aquaporin 4 in cell injury. Hum Mol Genet 2008;17:440\u201357. https:\/\/doi.org\/10.1093\/hmg\/ddm322.","DOI":"10.1093\/hmg\/ddm322"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_061","doi-asserted-by":"crossref","unstructured":"Gazzolo, D, Bruschettini, M, Corvino, V, Lituania, M, Sarli, R, Bruschettini, P, et al.. Amniotic fluid levels of S100B protein in normal and trisomy-21 foetuses. Clin Chim Acta 2003;330:131\u20133. https:\/\/doi.org\/10.1016\/s0009-8981(03)00010-x.","DOI":"10.1016\/S0009-8981(03)00010-X"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_062","doi-asserted-by":"crossref","unstructured":"Himmelmann, K, Hagberg, G, Beckung, E, Hagberg, B, Uvebrant, P. The changing panorama of cerebral palsy in Sweden. IX. Prevalence and origin in the birth-year period 1995\u20131998. Acta Paediatr 2005;94:287\u201394. https:\/\/doi.org\/10.1111\/j.1651-2227.2005.tb03071.x.","DOI":"10.1111\/j.1651-2227.2005.tb03071.x"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_063","doi-asserted-by":"crossref","unstructured":"Kingdom, J, Ashwal, E, Lausman, A, Liauw, J, Soliman, N, Figueiro-Filho, E, et al.. Guideline no. 442: fetal growth restriction: screening, diagnosis, and management in singleton pregnancies. J Obstet Gynaecol Can 2023;45:102154. https:\/\/doi.org\/10.1016\/j.jogc.2023.05.022.","DOI":"10.1016\/j.jogc.2023.05.022"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_064","doi-asserted-by":"crossref","unstructured":"Velipa\u015fao\u011flu, M, Yurdak\u00f6k, M, \u00d6zy\u00fcnc\u00fc, \u00d6, Portakal, O, Deren, \u00d6. Neuronal injury markers to predict neonatal complications in intrauterine growth restriction. J Obstet Gynaecol 2015;35:555\u201360. https:\/\/doi.org\/10.3109\/01443615.2014.978848.","DOI":"10.3109\/01443615.2014.978848"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_065","doi-asserted-by":"crossref","unstructured":"Swissa, SS, Baron, J, Tirosh, D, Beharier, O. S100B in maternal circulation of pregnancies complicated by fetal growth restriction and brain sparing. Prenat Diagn 2022;42:1509\u201315.","DOI":"10.1002\/pd.6045"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_066","doi-asserted-by":"crossref","unstructured":"Boutsikou, T, Mastorakos, G, Kyriakakou, M, Margeli, A, Hassiakos, D, Papassotiriou, I, et al.. Circulating levels of inflammatory markers in intrauterine growth restriction. Mediat Inflamm 2010;2010:790605\u201312. https:\/\/doi.org\/10.1155\/2010\/790605.","DOI":"10.1155\/2010\/790605"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_067","doi-asserted-by":"crossref","unstructured":"Mazarico, E, Llurba, E, Cumplido, R, Valls, A, Melchor, JC, Iglesias, M, et al.. Neural injury markers in intrauterine growth restriction and their relation to perinatal outcomes. Pediatr Res 2017;82:452\u20137. https:\/\/doi.org\/10.1038\/pr.2017.108.","DOI":"10.1038\/pr.2017.108"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_068","doi-asserted-by":"crossref","unstructured":"Mazarico, E, Llurba, E, Cabero, L, S\u00e1nchez, O, Valls, A, Mart\u00edn-Ancel, A, et al.. Associations between neural injury markers of intrauterine growth-restricted infants and neurodevelopment at 2 years of age. J Matern Fetal Neonatal Med 2019;32:3197\u2013203. https:\/\/doi.org\/10.1080\/14767058.2018.1460347.","DOI":"10.1080\/14767058.2018.1460347"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_069","doi-asserted-by":"crossref","unstructured":"Moodley, J. Maternal deaths due to hypertensive disorders in pregnancy. Best Pract Res Clin Obstet Gynaecol 2008;22:559\u201367. https:\/\/doi.org\/10.1016\/j.bpobgyn.2007.11.004.","DOI":"10.1016\/j.bpobgyn.2007.11.004"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_070","unstructured":"Podymow, T, August, P. Update on the use of antihypertensive drugs in pregnancy. Hypertension 2007;49:285\u201396."},{"key":"2026091512595703013_j_cclm-2025-1673_ref_071","doi-asserted-by":"crossref","unstructured":"Rutherford, JM, Moody, A, Crawshaw, S, Rubin, PC. Magnetic resonance spectroscopy in pre-eclampsia: evidence of cerebral ischaemia. BJOG 2003;4:416\u201323. https:\/\/doi.org\/10.1046\/j.1471-0528.2003.00416.x.","DOI":"10.1046\/j.1471-0528.2003.00416.x"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_072","doi-asserted-by":"crossref","unstructured":"Vettorazzi, J, Torres, FV, de \u00c1vila, TT, Martins-Costa, SH, Souza, DO, Portela, LV, et al.. Serum S100B in pregnancy complicated by preeclampsia: a case-control study. Pregnancy Hypertens 2012;2:101\u20135. https:\/\/doi.org\/10.1016\/j.preghy.2011.11.004.","DOI":"10.1016\/j.preghy.2011.11.004"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_073","doi-asserted-by":"crossref","unstructured":"Busse, M, Scharm, M, Oettel, A, Redlich, A, Costa, S-D, Zenclussen, AC. Enhanced S100B expression in T and B lymphocytes in spontaneous preterm birth and preeclampsia. J Perinat Med 2022;50:157\u201366. https:\/\/doi.org\/10.1515\/jpm-2021-0326.","DOI":"10.1515\/jpm-2021-0326"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_074","doi-asserted-by":"crossref","unstructured":"Artunc-Ulk\u00fcmen, B, G\u00fcven\u00e7, Y, G\u00f6ker, A, G\u00f6z\u00fckara, C. Maternal serum S100-B, PAPP-A and IL-6 levels in severe preeclampsia. Arch Gynecol Obstet 2015;292:97\u2013102. https:\/\/doi.org\/10.1007\/s00404-014-3610-0.","DOI":"10.1007\/s00404-014-3610-0"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_075","doi-asserted-by":"crossref","unstructured":"Friis, T, Wikstr\u00f6m, A-K, Acurio, J, Le\u00f3n, J, Zetterberg, H, Blennow, K, et al.. Cerebral biomarkers and blood\u2013brain barrier integrity in preeclampsia. Cells 2022;11:789. https:\/\/doi.org\/10.3390\/cells11050789.","DOI":"10.3390\/cells11050789"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_076","doi-asserted-by":"crossref","unstructured":"Yan, A. Application value of serum S100B combined with glucose metabolism indexes in predicting adverse pregnancy outcomes of patients with severe preeclampsia. J Hum Hypertens 2024;38:232\u20137. https:\/\/doi.org\/10.1038\/s41371-023-00887-x.","DOI":"10.1038\/s41371-023-00887-x"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_077","unstructured":"Wu, J, Sheng, X, Zhou, S, Fang, C, Song, Y, Wang, H, et al.. Clinical significance of S100B protein in pregnant women with early-onset severe preeclampsia. Ginekol Pol 2021;92:1\u201310."},{"key":"2026091512595703013_j_cclm-2025-1673_ref_078","doi-asserted-by":"crossref","unstructured":"Zhu, Y, Zhang, C. Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diabetes Rep 2016;16:1\u201311. https:\/\/doi.org\/10.1007\/s11892-015-0699-x.","DOI":"10.1007\/s11892-015-0699-x"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_079","doi-asserted-by":"crossref","unstructured":"Abella, L, D\u2019Adamo, E, Strozzi, M, Sanchez-de-Toledo, J, Perez-Cruz, M, G\u00f3mez, O, et al.. S100B maternal blood levels in gestational diabetes mellitus are birthweight, gender and delivery mode dependent. Int J Environ Res Publ Health 2021;19:1028. https:\/\/doi.org\/10.3390\/ijerph19031028.","DOI":"10.3390\/ijerph19031028"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_080","doi-asserted-by":"crossref","unstructured":"Gazzolo, D, Bruschettini, M, Di Iorio, R, Marinoni, E, Lituania, M, Marras, M, et al.. Maternal nitric oxide supplementation decreases cord blood S100B in intrauterine growth retarded fetuses. Clin Chem 2002;48:647\u201350. https:\/\/doi.org\/10.1093\/clinchem\/48.4.647.","DOI":"10.1093\/clinchem\/48.4.647"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_081","doi-asserted-by":"crossref","unstructured":"Kaandorp, JJ, Benders, MJNL, Schuit, E, Rademaker, CMA, Oudijk, MA, Porath, MM, et al.. Maternal allopurinol administration during suspected fetal hypoxia: a novel neuroprotective intervention? Arch Dis Child Fetal Neonatal Ed 2015;100:F216\u201323. https:\/\/doi.org\/10.1136\/archdischild-2014-306769.","DOI":"10.1136\/archdischild-2014-306769"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_082","doi-asserted-by":"crossref","unstructured":"Gazzolo, D, Kornacka, M, Bruschettini, M, Lituania, M, Giovannini, L, Serra, G, et al.. Maternal glucocorticoid supplementation and S100B protein concentrations in cord blood: correlations and urine of preterm infants. Clin Chem 2003;49:121\u20133.","DOI":"10.1373\/49.7.1215"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_083","doi-asserted-by":"crossref","unstructured":"Sannia, A, Risso, FM, Serpero, LD, Frulio, R, Michetti, F, Abella, R, et al.. Antenatal glucocorticoid treatment affects preterm infants\u2019 S100B urine concentration in a dose-dependent manner. Clin Chim Acta 2010;411:1539\u201341. https:\/\/doi.org\/10.1016\/j.cca.2010.05.045.","DOI":"10.1016\/j.cca.2010.05.045"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_084","doi-asserted-by":"crossref","unstructured":"Fuma, K, Kotani, T, Ushida, T, Imai, K, Iitani, Y, Nakamura, N, et al.. Antenatal corticosteroids-to-delivery interval associates cord blood S100B levels. J Obstet Gynaecol Res 2023;49:1129\u201336. https:\/\/doi.org\/10.1111\/jog.15582.","DOI":"10.1111\/jog.15582"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_085","unstructured":"Kahyaoglu, I, Kayikcioglu, F, G\u00fccel, F, Demirtas, C, Ozdemirci, S, Mollamahmutoglu, L. Umbilical cord S100B levels in active and passive smoker women. Eur Rev Med Pharmacol Sci 2014;18:723\u20137."},{"key":"2026091512595703013_j_cclm-2025-1673_ref_086","doi-asserted-by":"crossref","unstructured":"Bennett, HA, Einarson, A, Taddio, A, Koren, G, Einarson, TR. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol 2004;103:698\u2013709. https:\/\/doi.org\/10.1097\/01.aog.0000116689.75396.5f.","DOI":"10.1097\/01.AOG.0000116689.75396.5f"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_087","doi-asserted-by":"crossref","unstructured":"Pawluski, JL, Galea, LAM, Brain, U, Papsdorf, M, Oberlander, TF. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors. Pediatrics 2009;124:e662\u201370. https:\/\/doi.org\/10.1542\/peds.2009-0442.","DOI":"10.1542\/peds.2009-0442"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_088","doi-asserted-by":"crossref","unstructured":"Pawluski, JL, Brain, U, Hammond, GL, Oberlander, TF. Selective serotonin reuptake inhibitor effects on neural biomarkers of maternal depression during pregnancy: serum BDNF and S100B. Arch Womens Ment Health 2019;22:407\u20138.","DOI":"10.1007\/s00737-018-0931-1"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_089","doi-asserted-by":"crossref","unstructured":"Whitaker-Azmitia, PM, Murphy, R, Azmitia, EC. Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor protein S-100, and alters astroglial morphology. Brain Res 1990;528:155\u20138. https:\/\/doi.org\/10.1016\/0006-8993(90)90210-3.","DOI":"10.1016\/0006-8993(90)90210-3"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_090","doi-asserted-by":"crossref","unstructured":"Stroth, N, Svenningsson, P. S100B interacts with the serotonin 5-HT7 receptor to regulate a depressive-like behavior. Eur Neuropsychopharmacol 2015;25:2372\u201380. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.10.003.","DOI":"10.1016\/j.euroneuro.2015.10.003"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_091","doi-asserted-by":"crossref","unstructured":"Bellissima, V, Visser, GH, Ververs, TF, van Bel, F, Termote, JU, van der Heide, M, et al.. Antenatal maternal antidepressants drugs treatment affects S100B levels in maternal\u2013fetal biological fluids in a dose-dependent manner. Clin Chim Acta 2020;506:208\u201314. https:\/\/doi.org\/10.1016\/j.cca.2019.11.027.","DOI":"10.1016\/j.cca.2019.11.027"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_092","doi-asserted-by":"crossref","unstructured":"Martins, JG, Biggio, JR, Abuhamad, A. Diagnosis and management of fetal growth restriction. Am J Obstet Gynecol 2020;223:B2\u201317. https:\/\/doi.org\/10.1016\/j.ajog.2020.05.010.","DOI":"10.1016\/j.ajog.2020.05.010"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_093","doi-asserted-by":"crossref","unstructured":"Teka, H, Alemayehu, M, Yemane, A, Abera, BT, Tadesse, H, Berhe, E, et al.. Magnitude and determinants of adverse perinatal outcomes of pregnancies complicated with preeclampsia and eclampsia at a teaching hospital in the Tigray region of Ethiopia. Sci Rep 2025;15:36883. https:\/\/doi.org\/10.1038\/s41598-025-20802-3.","DOI":"10.1038\/s41598-025-20802-3"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_094","doi-asserted-by":"crossref","unstructured":"von Dadelszen, P, Syngelaki, A, Akolekar, R, Magee, LA, Nicolaides, KH. Preterm and term pre-eclampsia: relative burdens of maternal and perinatal complications. BJOG 2023;130:524\u201330. https:\/\/doi.org\/10.1111\/1471-0528.17370.","DOI":"10.1111\/1471-0528.17370"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_095","doi-asserted-by":"crossref","unstructured":"Magee, LA, Nicolaides, KH, von Dadelszen, P. Preeclampsia. N Engl J Med 2022;386:1817\u201332. https:\/\/doi.org\/10.1056\/NEJMra2109523.","DOI":"10.1056\/NEJMra2109523"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_096","doi-asserted-by":"crossref","unstructured":"Onuoha, C, Schulte, C, Thaweethai, T, Hsu, S, Pant, D, James, KE, et al.. The simultaneous occurrence of gestational diabetes and hypertensive disorders of pregnancy affects fetal growth and neonatal morbidity. Am J Obstet Gynecol 2024;231:548. https:\/\/doi.org\/10.1016\/j.ajog.2024.03.009.","DOI":"10.1016\/j.ajog.2024.03.009"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_097","doi-asserted-by":"crossref","unstructured":"Sharma, KJ, Esakoff, TF, Guillet, A, Burwick, RM, Caughey, AB. Pregnancies complicated by both preeclampsia and growth restriction between 34 and 37\u00a0weeks\u2019 gestation are associated with adverse perinatal outcomes. J Matern Fetal Neonatal Med 2017;30:2342\u20135. https:\/\/doi.org\/10.1080\/14767058.2016.1248394.","DOI":"10.1080\/14767058.2016.1248394"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_098","doi-asserted-by":"crossref","unstructured":"Al Darwish, FM, Chou, D, Afshar, Y. From molecules to imaging: assessment of placental hypoxia biomarkers in placental insufficiency syndromes. Cell 2023;12:2080.","DOI":"10.3390\/cells12162080"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_099","doi-asserted-by":"crossref","unstructured":"Adamova, P, Lotto, RR, Powell, AK, Dykes, IM. Are there foetal extracellular vesicles in maternal blood? Prospects for diagnostic biomarker discovery. J Mol Med (Berl) 2023;101:65\u201381. https:\/\/doi.org\/10.1007\/s00109-022-02278-0.","DOI":"10.1007\/s00109-022-02278-0"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_100","doi-asserted-by":"crossref","unstructured":"Estrela, D, Santos, RF, Masserdotti, A, Silini, A, Parolini, O, Pinto, IM, et al.. Molecular biomarkers for timely and personalized prediction of maternal-fetal health risk. Biomolecules 2025;15:312. https:\/\/doi.org\/10.3390\/biom15030312.","DOI":"10.3390\/biom15030312"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_101","doi-asserted-by":"crossref","unstructured":"Degnes, ML, Westerberg, AC, Zucknick, M, Powell, TL, Jansson, T, Henriksen, T, et al.. Placenta-derived proteins across gestation in healthy pregnancies\u2014a novel approach to assess placental function? BMC Med 2022;20:227. https:\/\/doi.org\/10.1186\/s12916-022-02415-z.","DOI":"10.1186\/s12916-022-02415-z"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_102","doi-asserted-by":"crossref","unstructured":"Gazzolo, D, Pluchinotta, F, Lapergola, G, Franchini, S. The Ca(2+)-binding S100B protein: an important diagnostic and prognostic neurobiomarker in pediatric laboratory medicine. Methods Mol Biol 2019;1929:701\u201328. https:\/\/doi.org\/10.1007\/978-1-4939-9030-6_44.","DOI":"10.1007\/978-1-4939-9030-6_44"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_103","doi-asserted-by":"crossref","unstructured":"Munoz Pareja, JC, de Rivero Vaccari, JP, Chavez, MM, Kerrigan, M, Pringle, C, Guthrie, K, et al.. Prognostic and diagnostic utility of serum biomarkers in pediatric traumatic Brain injury. J Neurotrauma 2024;41:106\u201322. https:\/\/doi.org\/10.1089\/neu.2023.0039.","DOI":"10.1089\/neu.2023.0039"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_104","doi-asserted-by":"crossref","unstructured":"Oris, C, Pereira, B, Durif, J, Simon-Pimmel, J, Castellani, C, Manzano, S, et al.. The biomarker S100B and mild traumatic brain injury: a meta-analysis. Pediatrics 2018;141:e20180037. https:\/\/doi.org\/10.1542\/peds.2018-0037.","DOI":"10.1542\/peds.2018-0037"},{"key":"2026091512595703013_j_cclm-2025-1673_ref_105","doi-asserted-by":"crossref","unstructured":"Perrotta, M, D\u2019Adamo, E, Strozzi, C, D\u2019Egidio, C, Del Rosso, F, Maconi, A, et al.. Capillary blood parameters are gestational age, birthweight, delivery mode and gender dependent in healthy preterm and term infants. Clin Chem Lab Med 2024;63:177\u201383. https:\/\/doi.org\/10.1515\/cclm-2024-0821.","DOI":"10.1515\/cclm-2024-0821"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-1673\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-1673\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:03:24Z","timestamp":1789477404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-1673\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":105,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,3,13]]},"published-print":{"date-parts":[[2026,8,24]]}},"alternative-id":["10.1515\/cclm-2025-1673"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2025-1673","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]}}}